Movement Disorders

Papers
(The H4-Index of Movement Disorders is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
In Memoriam Mahlon R. DeLong (1938–2024)513
John Michael Walshe (April 24, 1920–October 14, 2022)188
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease145
Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism134
Mortality of People with Parkinson's Disease in a Large UK‐Based Cohort Study: Time Trends and Relationship to Disease Duration126
108
YY1: A New Gene for Childhood Onset Dystonia with Prominent Oromandibular‐Laryngeal Involvement?98
Substantia Nigra Elasticity Measurement Using Transcranial Shear Wave Elastography: A Potential Biomarker for Parkinson's Disease98
Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals97
Neuroinflammation in the Cerebellum and Brainstem in Friedreich Ataxia: An [18F]‐FEMPA PET Study88
Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation85
The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?83
Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease81
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA‐Ataxia80
Classifying Idiopathic Rapid Eye Movement Sleep Behavior Disorder, Controls, and Mild Parkinson's Disease Using Gait Parameters77
The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?70
Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical Rating70
X‐Linked Dystonia‐Parkinsonism (“Lubag”) May Present with Peripheral Synucleinopathy69
Deep Brain Stimulation of the Globus Pallidus Internus and Externus in Multiple System Atrophy68
Fixel‐Based Analysis Reveals Whole‐Brain White Matter Abnormalities in Cervical Dystonia68
Bidirectional Transcription at the PPP2R2B Gene Locus in Spinocerebellar Ataxia Type 1264
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy63
Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials63
Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model62
Dual Task Turning in Place: A Reliable, Valid, and Responsive Outcome Measure of Freezing of Gait61
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease60
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure60
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property59
May Infographic58
Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism58
Movement Disorders: Volume 40, Number 6, June 202557
Movement Disorders: Volume 40, Number 2, February 202556
Issue Information56
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers55
Obituary for Jan O. Aasly (1950–2022)54
Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and 18F‐Fluorodopa‐Positron Emission Tomography52
Author Index52
Thank you to Reviewers 202252
52
Downbeat Nystagmus in Episodic Ataxia Type 1 Associated with a Novel KCNA1 Mutation51
Diagnostic and Prognostic Value of External Anal SphincterEMGPatterns in Multiple System Atrophy50
Effect of Public Interest in Magnetic Resonance Imaging–Guided Focused Ultrasound on Enrolment for Deep Brain Stimulation50
Reply to: “Application of the mPSPRS to the Salerno Cohort”49
Cortical Functional Connectivity Changes in the Body‐First and Brain‐First Subtypes of Parkinson's Disease49
In Vivo Investigation of Glucose Metabolism in Idiopathic and PRKN‐Related Parkinson's Disease47
Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis45
0.073745012283325